PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy

Background: Activation of central serotonin (5-HT)1A receptors, found in high density in brainstem raphe, hippocampus, and temporal neocortex, exerts an anticonvulsant effect in various experimental seizure models. To test the hypothesis that 5-HT1A receptor binding is reduced in human epileptic foci, PET imaging was performed using the radioligand [18F]trans-4-fluoro-N-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide ([18F]FCWAY), a selective 5-HT1A receptor antagonist, in patients with temporal lobe epilepsy and normal controls. Methods: MRI and PET were performed using [15O]water and [18F]FCWAY in 10 controls and in 12 patients with temporal lobe epilepsy confirmed on ictal video-EEG; patients also underwent [18F]fluorodeoxyglucose PET. Using quantitative PET image analysis, regional values were obtained for [18F]FCWAY volume of distribution (V), cerebral blood flow (CBF), and glucose cerebral metabolic rate (CMRglc). Hippocampal volume (HV) was also measured with MRI. [18F]FCWAY V PET and MR measures were compared within patients and controls using paired t-tests; grouped comparisons were made with two sample t-tests. Results: Lower [18F]FCWAY V was found ipsilateral than contralateral to the epileptic focus in inferior medial (IMT) and lateral (ILT) temporal regions of patients (ILT 47.4 ± 6.1 vs 61.8 ± 6.1, p < 0.01; IMT 52 ± 4.6 vs 67.0 ± 6.0, p < 0.01). [18F]FCWAY V was 29% lower in raphe and 34% lower in the ipsilateral thalamic region of patients than controls. In ILT, mean [18F]FCWAY V asymmetry index (AI) was significantly greater than mean CBF and mean CMRglc AI. Mean [18F]FCWAY V AI in IMT was greater than mean HV AI, but the difference was not significant. Conclusion: These findings support the hypothesis of reduced serotonin receptor binding in temporal lobe epileptic foci.

[1]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[2]  Peter Herscovitch,et al.  Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to [18F]Cyclofoxy and Positron Emission Tomography , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  R. Nicoll,et al.  Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. , 1987, The Journal of physiology.

[4]  M Diksic,et al.  Localizing value of α-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin , 2001, Neurology.

[5]  E. Hoffman,et al.  Validation of PET-acquired input functions for cardiac studies. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  R A Brooks,et al.  Alternative formula for glucose utilization using labeled deoxyglucose. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  P A Sargent,et al.  Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. , 1996, European journal of pharmacology.

[8]  Nariyoshi Yamaguchi,et al.  Role of serotonin receptor subtype in seizures kindled from the feline hippocampus , 1992, Neuroscience Letters.

[9]  P. Van Bogaert,et al.  Comparative study of hippocampal neuronal loss and in vivo binding of 5-HT1a receptors in the KA model of limbic epilepsy in the rat , 2001, Epilepsy Research.

[10]  P. Gean,et al.  Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation , 1998, Neuroscience.

[11]  S. Yamawaki,et al.  Repeated treatment with electroconvulsive shock increases numbers of serotonin1A receptors in the rat hippocampus , 1993 .

[12]  M. Reith,et al.  Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships , 1997, Neuroscience Letters.

[13]  O Muzik,et al.  Imaging epileptogenic tubers in children with tuberous sclerosis complex usingα‐[11C]Methyl‐L‐tryptophan positron emission tomography , 1998, Annals of neurology.

[14]  Claudette Boni,et al.  Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine , 2000, Neuropharmacology.

[15]  S. Weinstein,et al.  Low incidence of abnormal 18FDG-PET in children with new-onset partial epilepsy: A prospective study , 2002, Neurology.

[16]  N. J. Giarman,et al.  Anticonvulsant compounds and 5-hydroxytryptamine in rat brain. , 1957, British journal of pharmacology and chemotherapy.

[17]  A. Phillips,et al.  The effects of serotonergic compounds on evoked responses in the dentate gyrus and CA1 region of the hippocampal formation of the rat , 1991, Neuropharmacology.

[18]  R. A. Browning,et al.  Abnormalities in 5-HT1A and 5-HT1B receptor binding in severe-seizure genetically epilepsy-prone rats (GEPR-9s) , 1996, Neuropharmacology.

[19]  E. Hoffman,et al.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.

[20]  S. Beck,et al.  5-HT1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells. , 1994, Journal of neurophysiology.

[21]  V J Cunningham,et al.  11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy , 1997, Neurology.

[22]  Robert M. Post,et al.  Autoradiographic analysis of serotonin receptors and transporter in kindled rat brain , 1993, Neuroscience Letters.

[23]  F. Moroni,et al.  Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. , 1999, European journal of pharmacology.

[24]  Nariyoshi Yamaguchi,et al.  Intra-hippocampal injection of 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats , 1993, Neuroscience Letters.

[25]  A. Vezzani,et al.  Stimulation of 5‐HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats , 1996, British journal of pharmacology.

[26]  L. Mancini,et al.  Lasting Increase in Serotonin 5‐HT1A but Not 5‐HT4 Receptor Subtypes in the Kindled Rat Dentate Gyrus: Dissociation from Local Presynaptic Effects , 1998, Journal of neurochemistry.

[27]  D. Salgado-Commissariat,et al.  Serotonin inhibits epileptiform discharge by activation of 5-HT1A receptors in CA1 pyramidal neurons , 1997, Neuropharmacology.

[28]  A Malizia,et al.  First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635. , 1995, European journal of pharmacology.

[29]  E. Hoffman,et al.  TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.

[30]  Allan Fletcher,et al.  Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist , 1995, Behavioural Brain Research.

[31]  K. Alkadhi,et al.  Inhibition of epileptiform activity by serotonin in rat CA1 neurons , 1995, Brain Research.

[32]  L. Fowler,et al.  Regional Effects of Sodium Valproate on Extracellular Concentrations of 5‐Hydroxytryptamine, Dopamine, and Their Metabolites in the Rat Brain: An In Vivo Microdialysis Study , 1992, Journal of neurochemistry.

[33]  R. L. Burger,et al.  Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. , 1992, The Journal of pharmacology and experimental therapeutics.

[34]  M Toth,et al.  Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  W H Theodore,et al.  Effect of Valproate on Cerebral Metabolism and Blood Flow: An 18F‐2‐Deoxyglusose and 15O Water Positron Emission Tomography Study , 1996, Epilepsia.

[36]  T Revesz,et al.  Central benzodiazepine receptor autoradiography in hippocampal sclerosis , 1997, British journal of pharmacology.

[37]  M. Raichle,et al.  Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  Paul J. Harrison,et al.  The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain , 1995, Brain Research.

[39]  W C Eckelman,et al.  PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635. , 2000, Nuclear medicine and biology.

[40]  S. Beck,et al.  5-Hydroxytryptamine hyperpolarizes CA3 hippocampal pyramidal cells through an increase in potassium conductance , 1991, Neuroscience Letters.

[41]  O. Muzik,et al.  α[C-11]Methyl-l-Tryptophan PET Maps Brain Serotonin Synthesis and Kynurenine Pathway Metabolism , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[42]  D J Kupfer,et al.  Serotonin type-1A receptor imaging in depression. , 2000, Nuclear medicine and biology.

[43]  H. Wikström,et al.  Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635 , 1997, Brain Research.

[44]  S. Maayani,et al.  Lack of 5-hydroxytryptamine1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats. , 1996, The Journal of pharmacology and experimental therapeutics.

[45]  C. Decarli,et al.  Extratemporal atrophy in patients with complex partial seizures of left temporal origin , 1998, Annals of neurology.

[46]  A. Wyler,et al.  Levels of biogenic amines, their metabolites, and tyrosine hydroxylase activity in the human epileptic temporal cortex , 1990, Synapse.

[47]  W C Eckelman,et al.  Development of fluorine-18-labeled 5-HT1A antagonists. , 1999, Journal of medicinal chemistry.

[48]  L. Spinelli,et al.  Volumetric measurements of subcortical nuclei in patients with temporal lobe epilepsy , 2001, Neurology.

[49]  H. Duvernoy,et al.  The Human Hippocampus: Functional Anatomy, Vascularization and Serial Sections with MRI , 1997 .

[50]  G. Higgins,et al.  Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats. , 1998, European journal of pharmacology.